Achieving widespread immunity to COVID-19 through vaccination requires as many people as possible to get their shots, including those who object or haven’t bothered.
Academic rigour, journalistic flair
Articles on Vaccine hesitancy
Displaying 81 - 100 of 206 articles
The U.S. FDA has approved the first COVID-19 vaccine. How is approval different from emergency use authorization, and what difference will it make to a vaccine that’s already in global use?
Anti-vaccine activists are using the side effect reporting system to spread fear and misinformation about the COVID-19 vaccines. But the database could also be used as a gauge for public concerns.
There is an urgent need to combat historically fuelled vaccine hesitancy within Indigenous communities. The best way to do this is through evidence-based knowledge and community-led work.
For the one in 10 people with a significant fear of needles, getting a vaccination is distressing. This can disrupt vaccination campaigns, but there are effective ways to manage pain and fear.
Coverage of Russian vaccination rollout has focused largely on concerns about ethics of development and inconsistent messaging. But Russian-language research complicates this picture.
Too much of our discussion about vaccine hesitancy imagines the problem in rational terms. Perceptions about COVID-19 and vaccines are driven by emotion, not reason.
Research shows Australians are broadly supportive of vaccine mandates. But to appear legitimate, a mandate needs to serve clearly articulated public health goals and be proportionate.
14% of Australians aged 18-49 are unwilling to get vaccinated, and almost 15% are unsure.
America’s founders accepted the reality of human selfishness. But, they also said people were capable of thinking for the good of the whole, which is necessary for a free society.
The new Delta variant presents a considerable threat due to its significantly increased transmissibility rather than severity.
The circulation of misinformation about the COVID-19 vaccine poses the danger of hampering the government’s efforts to control the pandemic.
Vaccine hesitancy is declining in Canada but hasn’t disappeared. New research shows many of those initially less hesitant have since been convinced. With continued efforts, others can still be reached.
If Australians won’t take the AstraZeneca vaccine, we must donate it to save lives elsewhere, especially while we queue-jump for more Pfizer doses.
Simultaneously high levels of virus and vaccination will give further evidence of just how protective COVID-19 vaccines are.
The US has split into “two Americas,” one of the unvaccinated and one of the vaccinated. The differences in deaths and hospitalizations between the two populations are striking.
Vaccinating a population requires a proactive approach to health promotion and community preparedness.
Comparing COVID-19 vaccines with others that are less effective makes people see them more favourably.
Vaccine hesitancy in parents shouldn’t mean adolescents can’t get vaccinated.
Some deaths among the vaccinated are to be expected given how high the threat of COVID-19 is to older people.
Job Board
-
Team Leader, Admissions, Future Students
-
Economics Editor
-
Deputy Vice-Chancellor (Indigenous Strategy and Services)
-
Chief People & Culture Officer
-
Lecturer / Senior Lecturer in Construction and Project Management
Top contributors
-
Associate Professor, School of Population Health, UNSW Sydney
-
Assistant Professor of Political Science, Oklahoma State University
-
Professor of Paediatrics and vaccinologist, Royal Childrens Hospital, University of Melbourne and Murdoch Childrens Research Institute (MCRI); Associate Dean International, University of Melbourne, Murdoch Children's Research Institute
-
Research Fellow, Vaccine Uptake Group, Murdoch Children's Research Institute
-
Associate Professor, School of Social Sciences, The University of Western Australia
-
Regional Adviser, Immunisation, WHO Regional Office for Africa, Stellenbosch University
-
Professor, Susan Wakil School of Nursing and Midwifery, University of Sydney
-
Assistant Professor of Health Policy and Managment, School of Public Health, Texas A&M University
-
Senior Lecturer, School of Communication, Journalism and Marketing, Te Kunenga ki Pūrehuroa – Massey University
-
Executive Director, African Population and Health Research Center
-
Senior Scientist, Cochrane South Africa, South African Medical Research Council (SAMRC) and Honorary researcher, Division of Social & Behavioural Sciences, School of Public Health, UCT, South African Medical Research Council
-
Postdoctoral Associate in Behavioral and Community Health Sciences, University of Pittsburgh
-
Associate Head (Students), School of Biological Sciences, University of Portsmouth
-
Associate Dean for Public Health Integration, Michigan State University
-
Professor of Toxicology, Equity and Inclusive Practice, Director of Impact and Innovation, University of East London
